Profitable failure: antidepressant drugs and the triumph of flawed experiments
Drawing on an analysis of Irving Kirsch and colleagues’ controversial 2008 article in PLoS [Public Library of Science] Medicine on the efficacy of SSRI antidepressant drugs such as Prozac, I examine flaws within the methodologies of randomized controlled trials (RCTs) that have made it difficult f...
1. Verfasser: | McGoey, L |
---|---|
Format: | Journal article |
Veröffentlicht: |
SAGE Publications
2010
|
Ähnliche Einträge
Ähnliche Einträge
-
Methodological mimesis and the value of pharmaceutical failures
von: McGoey, L
Veröffentlicht: (2009) -
Experimental dissidence: economies of credibility in drug regulation
von: McGoey, L
Veröffentlicht: (2010) -
Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
von: McGoey, L, et al.
Veröffentlicht: (2008) -
The windfalls after the storm
von: McGoey, L
Veröffentlicht: (2007) -
The Politics of Personalised Medicine: Pharmacogenetics in the Clinic By Adam Hedgecoe
von: McGoey, L
Veröffentlicht: (2007)